The Proprietary Products segment involves the discovery of new chemical entities for subsequent commercialization and out - licensing. (borntosell.com)
We have a common vested interest in identifying new targets, developing assays, and synthesizing new chemical entities for use as biological probes and, ultimately, new drug therapeutics. (wistar.org)
DURECT Corp. is a biopharmaceutical company focused on two areas of active drug development: New therapeutics based on its proprietary drug delivery platforms and new chemical entities derived from its epigenomic regulator program. (thelifesciencesreport.com)